Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years
- 1 July 1998
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (8) , 1204-1207
- https://doi.org/10.1016/s0959-8049(98)00059-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.Journal of Clinical Oncology, 1995
- Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumours, 1979 to 1989BJOG: An International Journal of Obstetrics and Gynaecology, 1991
- The role of low‐dose methotrexate and folinic acid in gestational trophoblastic tumours (GTT)BJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Developments in chemotherapy for medium‐ and high‐risk patients with gestational trophoblastic tumours (1979–1984)BJOG: An International Journal of Obstetrics and Gynaecology, 1986
- Reproductive Performance After Molar Pregnancy and Gestational Trophoblastic TumorsClinical Obstetrics and Gynecology, 1984
- Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumours.BMJ, 1984
- Long-term follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's diseaseThe American Journal of Medicine, 1981
- Female Reproductive Potential after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1981
- Risk and prognostic factors in trophoblastic neoplasiaCancer, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958